Prevention of contrast-induced nephropathy by chronic pravastatin treatment in patients with cardiovascular disease and renal insufficiency.

Abstract

BACKGROUND Contrast-induced nephropathy (CIN) is known to increase morbidity and mortality of cardiovascular disease. Recent studies have shown statins prevented CIN after contrast media exposure, but optimal statin type and dosage are still unknown. PURPOSE The aims of the present study were to evaluate whether chronic pravastatin treatment before… (More)
DOI: 10.1016/j.jjcc.2009.05.006

Cite this paper

@article{Yoshida2009PreventionOC, title={Prevention of contrast-induced nephropathy by chronic pravastatin treatment in patients with cardiovascular disease and renal insufficiency.}, author={Susumu Yoshida and Hiroshi Kamihata and Seishi Nakamura and Takeshi Senoo and Kenichi Manabe and Masayuki Motohiro and Tetsuro Sugiura and Toshiji Iwasaka}, journal={Journal of cardiology}, year={2009}, volume={54 2}, pages={192-8} }